State Ledger
Company profile

Akebia Therapeutics, Inc. CIK 1517022

Ticker
AKBA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02142
Fiscal year end
2025 (FY)
Market Data
Close
$0.79
Change
-$0.02
Change %
-2.46%
Volume
120,836

AKBA · trading date Oct 12, 2026 · previous close $0.81 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$236.20M
Net income
-$5.35M
Total assets
$376.57M
Total liabilities
$343.96M
Stockholders' equity
$32.61M
Cash & equivalents
$184.84M
Operating income
$23.50M
Operating cash flow
$67.99M
Capital expenditures
$291.0K

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
9.9%
Net margin
-2.3%
Free cash flow
$67.70M
Free cash flow margin
28.7%
Liabilities / assets
91.3%
Equity / assets
8.7%
CapEx / revenue
0.1%
Operating cash flow / net income
-12.72×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $236.20M -$5.35M $376.57M $343.96M $32.61M
2024 $160.18M -$69.41M $220.67M $269.86M -$49.19M
2023 $194.62M -$51.93M $241.70M $272.29M -$30.58M
2022 $292.48M -$94.23M $356.05M $350.82M $5.23M
2021 $211.65M -$282.02M $529.35M $455.34M $74.01M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-10
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02142
245 FIRST STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies